{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:54:26Z","timestamp":1793382866035,"version":"4.5.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2020,11,22]],"date-time":"2020-11-22T00:00:00Z","timestamp":1606003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To carry out a review of clinical characteristics, laboratory profiles, management and outcomes of patients with Kawasaki disease (KD) and macrophage activation syndrome (MAS).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Medical records of patients treated for KD and MAS between January 1994 and December 2019 were reviewed. Patient demographics, clinical signs, laboratory values, coronary artery abnormalities, treatments and outcomes of patients with KD and MAS were recorded. We also performed a review published studies on the subject.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of the 950 cases with KD, 12 (1.3%; 10 boys, 2 girls) were diagnosed with MAS. The median age at diagnosis was 4\u2009years (range 9\u2009months\u20137.5\u2009years). The median interval between onset of fever and diagnosis of KD was 11\u2009days (range 6\u201330). Thrombocytopenia was seen in 11 patients. The median pro-brain natriuretic peptide value was 2101\u2009pg\/ml (range 164\u201375\u00a0911). Coronary artery abnormalities were seen in 5 (41.7%) patients; 2 had dilatation of the left main coronary artery (LMCA), 1 had dilatation of both the LMCA and right coronary artery (RCA), 1 had dilatation of the RCA and 1 had bright coronary arteries. All patients received IVIG as first-line therapy for KD. MAS was treated with i.v. methylprednisolone pulses followed by tapering doses of oral prednisolone. Additional therapy included i.v. infliximab (n\u2009=\u20094), second-dose IVIG (n\u2009=\u20091) and oral ciclosporin (n\u2009=\u20091).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>MAS is an unusual and underrecognized complication of KD. In our cohort of 950 patients with KD, 1.3% had developed MAS. KD with MAS is associated with an increased propensity towards development of coronary artery abnormalities.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa715","type":"journal-article","created":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T11:32:29Z","timestamp":1603452749000},"page":"3413-3419","source":"Crossref","is-referenced-by-count":31,"title":["Macrophage activation syndrome in children with Kawasaki disease: an experience from a tertiary care hospital in northwest India"],"prefix":"10.1093","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9015-1704","authenticated-orcid":false,"given":"Rakesh Kumar","family":"Pilania","sequence":"first","affiliation":[{"name":"Pediatric Allergy Immunology Unit, Advanced Pediatrics Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7954-0661","authenticated-orcid":false,"given":"Ankur Kumar","family":"Jindal","sequence":"additional","affiliation":[{"name":"Pediatric Allergy Immunology Unit, Advanced Pediatrics Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nameirakpam","family":"Johnson","sequence":"additional","affiliation":[{"name":"Pediatric Allergy Immunology Unit, Advanced Pediatrics Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwini","family":"Prithvi","sequence":"additional","affiliation":[{"name":"Pediatric Allergy Immunology Unit, Advanced Pediatrics Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pandiarajan","family":"Vignesh","sequence":"additional","affiliation":[{"name":"Pediatric Allergy Immunology Unit, Advanced Pediatrics Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepti","family":"Suri","sequence":"additional","affiliation":[{"name":"Pediatric Allergy Immunology Unit, Advanced Pediatrics Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5875-2892","authenticated-orcid":false,"given":"Amit","family":"Rawat","sequence":"additional","affiliation":[{"name":"Pediatric Allergy Immunology Unit, Advanced Pediatrics Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anju","family":"Gupta","sequence":"additional","affiliation":[{"name":"Pediatric Allergy Immunology Unit, Advanced Pediatrics Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8738-4582","authenticated-orcid":false,"given":"Surjit","family":"Singh","sequence":"additional","affiliation":[{"name":"Pediatric Allergy Immunology Unit, Advanced Pediatrics Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,11,22]]},"reference":[{"key":"2021070122133520700_keaa715-B1","doi-asserted-by":"crossref","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association","volume":"135","author":"McCrindle","year":"2017","journal-title":"Circulation"},{"key":"2021070122133520700_keaa715-B2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fimmu.2019.00119","article-title":"The immunology of macrophage activation syndrome","volume":"10","author":"Crayne","year":"2019","journal-title":"Front Immunol"},{"key":"2021070122133520700_keaa715-B3","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/annrheumdis-2015-208982","article-title":"2016 classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism\/American College of Rheumatology\/Paediatric Rheumatology International Trials Organisation Collaborative Initiative","volume":"75","author":"Ravelli","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2021070122133520700_keaa715-B4","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1080\/1744666X.2019.1659726","article-title":"Kawasaki disease: characteristics, diagnosis and unusual presentations","volume":"15","author":"Jindal","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"key":"2021070122133520700_keaa715-B5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00431-006-0258-1","article-title":"Familial and acquired hemophagocytic lymphohistiocytosis","volume":"166","author":"Janka","year":"2006","journal-title":"Eur J Pediatr"},{"key":"2021070122133520700_keaa715-B6","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"2021070122133520700_keaa715-B7","first-page":"1414","article-title":"Haemophagocytic syndrome in rheumatic patients. A systematic review","volume":"16","author":"Atteritano","year":"2012","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2021070122133520700_keaa715-B8","article-title":"Is macrophage activation syndrome in Kawasaki disease underrecognized?","author":"Natoli","year":"2020","journal-title":"J Rheumatol"},{"key":"2021070122133520700_keaa715-B9","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s12519-020-00360-6","article-title":"Macrophage activation syndrome in children with Kawasaki disease: diagnostic and therapeutic approaches","volume":"16","author":"Han","year":"2020","journal-title":"World J Pediatr"},{"key":"2021070122133520700_keaa715-B10","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/MPH.0000000000000872","article-title":"Kawasaki disease complicated with macrophage activation syndrome: a systematic review","volume":"39","author":"Garc\u00eda-Pav\u00f3n","year":"2017","journal-title":"J Pediatr Hematol Oncol"},{"key":"2021070122133520700_keaa715-B11","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/MPH.0b013e3181dccbf4","article-title":"Macrophage activation syndrome in the acute phase of Kawasaki disease","volume":"32","author":"Latino","year":"2010","journal-title":"J Pediatr Hematol Oncol"},{"key":"2021070122133520700_keaa715-B12","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1161\/01.CIR.0000145143.19711.78","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association","volume":"110","author":"Newburger","year":"2004","journal-title":"Circulation"},{"key":"2021070122133520700_keaa715-B13","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jpeds.2004.12.016","article-title":"Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis","volume":"146","author":"Ravelli","year":"2005","journal-title":"J Pediatr"},{"key":"2021070122133520700_keaa715-B14","doi-asserted-by":"crossref","DOI":"10.1097\/RHU.0000000000001349","article-title":"Transient erythroblastopenia: an unusual manifestation of macrophage activation syndrome in Kawasaki disease","author":"Pilania","year":"2020","journal-title":"J Clin Rheumatol"},{"key":"2021070122133520700_keaa715-B15","doi-asserted-by":"crossref","DOI":"10.1097\/RHU.0000000000001233","article-title":"Assessment of endothelial dysfunction in acute and convalescent phases of Kawasaki disease using automated edge detection software: a preliminary study from North India","author":"Routhu","year":"2019","journal-title":"J Clin Rheumatol"},{"key":"2021070122133520700_keaa715-B16","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3389\/fped.2020.00274","article-title":"CT coronary angiography studies after a mean follow-up of 3.8 years in children with Kawasaki disease and spontaneous defervescence","volume":"8","author":"Dusad","year":"2020","journal-title":"Front Pediatr"},{"key":"2021070122133520700_keaa715-B17","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1093\/rheumatology\/40.11.1285","article-title":"Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients","volume":"40","author":"St\u00e9phan","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"2021070122133520700_keaa715-B18","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3109\/08880018.2010.526685","article-title":"Clinical characteristics of hemophagocytic lymphohistiocytosis related to Kawasaki disease","volume":"28","author":"Kim","year":"2011","journal-title":"Pediatr Hematol Oncol"},{"key":"2021070122133520700_keaa715-B19","doi-asserted-by":"crossref","first-page":"254","DOI":"10.5045\/br.2013.48.4.254","article-title":"Clinical characteristics of hemophagocytic lymphohistiocytosis following Kawasaki disease: differentiation from recurrent Kawasaki disease","volume":"48","author":"Kang","year":"2013","journal-title":"Blood Res"},{"key":"2021070122133520700_keaa715-B20","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.semarthrit.2014.07.007","article-title":"Macrophage activation syndrome in Kawasaki disease: more common than we thought?","volume":"44","author":"Wang","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"2021070122133520700_keaa715-B21","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3345\/kjp.2018.61.5.167","article-title":"Differentiation between incomplete Kawasaki disease and secondary hemophagocytic lymphohistiocytosis following Kawasaki disease using N-terminal pro-brain natriuretic peptide","volume":"61","author":"Choi","year":"2018","journal-title":"Korean J Pediatr"},{"key":"2021070122133520700_keaa715-B22","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cyto.2019.03.001","article-title":"Cytokine profile of macrophage activation syndrome associated with Kawasaki disease","volume":"119","author":"Jinkawa","year":"2019","journal-title":"Cytokine"},{"key":"2021070122133520700_keaa715-B23","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s12519-019-00256-0","article-title":"Clinical and laboratory features, treatment, and outcomes of macrophage activation syndrome in 80 children: a multi-center study in China","volume":"16","author":"Zou","year":"2020","journal-title":"World J Pediatr"},{"key":"2021070122133520700_keaa715-B24","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1136\/annrheumdis-2016-209395","article-title":"Should 2016 criteria for macrophage activation syndrome be applied in children with Kawasaki disease, as well as with systemic-onset juvenile idiopathic arthritis?","volume":"75","author":"Han","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2021070122133520700_keaa715-B25","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00296-009-0947-y","article-title":"Thrombocytopenia as a presenting feature of Kawasaki disease: a case series from North India","volume":"30","author":"Singh","year":"2009","journal-title":"Rheumatol Int"},{"key":"2021070122133520700_keaa715-B26","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.semarthrit.2016.08.007","article-title":"Should refractory Kawasaki disease be considered occult macrophage activation syndrome?","volume":"46","author":"Choi","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"2021070122133520700_keaa715-B27","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s00431-005-1699-7","article-title":"Impact of increased D-dimer concentrations in Kawasaki disease","volume":"164","author":"Imamura","year":"2005","journal-title":"Eur J Pediatr"},{"key":"2021070122133520700_keaa715-B28","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/1744-9987.12235","article-title":"Elevated D-dimer level is a risk factor for coronary artery lesions accompanying intravenous immunoglobulin-unresponsive Kawasaki disease","volume":"19","author":"Masuzawa","year":"2015","journal-title":"Ther Apher Dial"},{"key":"2021070122133520700_keaa715-B29","first-page":"5121","article-title":"Correlations of complication with coronary arterial lesion with VEGF, PLT, D-dimer and inflammatory factor in child patients with Kawasaki disease","volume":"22","author":"Zhou","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/7\/3413\/38849930\/keaa715.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/7\/3413\/38849930\/keaa715.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T22:17:21Z","timestamp":1625177841000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/7\/3413\/5998388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,22]]},"references-count":29,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,11,22]]},"published-print":{"date-parts":[[2021,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa715","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,7,1]]},"published":{"date-parts":[[2020,11,22]]}}}